IBDEI0NM ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10631,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,10632,0)
 ;;=F02.80^^42^472^40
 ;;^UTILITY(U,$J,358.3,10632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10632,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss PARKINSON'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,10632,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,10632,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,10633,0)
 ;;=F02.81^^42^472^45
 ;;^UTILITY(U,$J,358.3,10633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10633,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob PARKINSON'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,10633,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,10633,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,10634,0)
 ;;=F02.80^^42^472^46
 ;;^UTILITY(U,$J,358.3,10634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10634,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob PARKINSON'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,10634,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,10634,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,10635,0)
 ;;=G31.84^^42^472^63
 ;;^UTILITY(U,$J,358.3,10635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10635,1,3,0)
 ;;=3^Mild Neurocog D/O d/t PARKINSON'S DISEASE
 ;;^UTILITY(U,$J,358.3,10635,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,10635,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,10636,0)
 ;;=A81.9^^42^472^72
 ;;^UTILITY(U,$J,358.3,10636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10636,1,3,0)
 ;;=3^Prion Disease
 ;;^UTILITY(U,$J,358.3,10636,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,10636,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,10637,0)
 ;;=F02.81^^42^472^33
 ;;^UTILITY(U,$J,358.3,10637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10637,1,3,0)
 ;;=3^Major Neurocog D/O d/t PRION DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,10637,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,10637,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,10638,0)
 ;;=F02.80^^42^472^34
 ;;^UTILITY(U,$J,358.3,10638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10638,1,3,0)
 ;;=3^Major Neurocog D/O d/t PRION DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,10638,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,10638,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,10639,0)
 ;;=G31.84^^42^472^64
 ;;^UTILITY(U,$J,358.3,10639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10639,1,3,0)
 ;;=3^Mild Neurocog D/O d/t PRION DISEASE
 ;;^UTILITY(U,$J,358.3,10639,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,10639,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,10640,0)
 ;;=S06.2X9S^^42^472^75
 ;;^UTILITY(U,$J,358.3,10640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10640,1,3,0)
 ;;=3^TRAUMATIC BRAIN INJURY,Diffuse w/ Unspec Duration of LOC,Sequela
 ;;^UTILITY(U,$J,358.3,10640,1,4,0)
 ;;=4^S06.2X9S
 ;;^UTILITY(U,$J,358.3,10640,2)
 ;;=^5020755
 ;;^UTILITY(U,$J,358.3,10641,0)
 ;;=F02.81^^42^472^51
 ;;^UTILITY(U,$J,358.3,10641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10641,1,3,0)
 ;;=3^Major Neurocog D/O d/t TBI w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,10641,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,10641,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,10642,0)
 ;;=F02.80^^42^472^52
 ;;^UTILITY(U,$J,358.3,10642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10642,1,3,0)
 ;;=3^Major Neurocog D/O d/t TBI w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,10642,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,10642,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,10643,0)
 ;;=G31.84^^42^472^65
 ;;^UTILITY(U,$J,358.3,10643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10643,1,3,0)
 ;;=3^Mild Neurocog D/O d/t TBI
